2026 NPPES data Rheumatology Physician NPI 1689085888 M.D.
Verify on CMS →

Anna Kazaryan, M.D.

Rheumatology Physician in Fresno, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,181 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 247 beneficiaries · Rheumatology Physician avg: 2K
MIPS score
84/100
▲ 1 pts above national avg 83.1 · Above neutral
Industry payments
$1.5K
78 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Anna Kazaryan, M.D. reported a CMS MIPS final score of 84/100 - above the 83.1 national average - and filed 1,087 Medicare Part D claims in 2023.

84/100
MIPS score · +1 vs avg
1K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Anna Kazaryan, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

84 45th percentile higher than 45% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Anna Kazaryan, M.D. sits

This provider among rheumatology physician peers

Across the 2,181 rheumatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Anna Kazaryan, M.D. writes more Part D claims than 28% of them and scores higher on MIPS quality than 47% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.949.974.899.8Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 30Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 52Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 82Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 45Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 18Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 52Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 50Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 62Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 73Anna Kazaryan, M.D.-Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 47
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one rheumatology physician peer from a representative sample of 60; the gold marker is Anna Kazaryan, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Anna Kazaryan, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Anna Kazaryan, M.D.?

Near national average

NPI registry status

Active

Issued 05/12/2014

NPI 1689085888

Primary specialty

Rheumatology Physician

Mid-sized

6,181 US NPIs in this specialty

Medicare Part D claims

1,087 47% vs specialty avg

2023 prescription claims

Specialty avg: 2,054

MIPS final score

84/100 0.9 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Rheumatology Physician compares to other specialties among California providers

California providers
Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%Rheumatology Physician - 0.1%Rheumatology Physician0.1%
Largest specialties in California (% of in-state providers)

Medicare quality performance, MIPS

Anna Kazaryan, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average

Near national average
MIPS Final Score
84/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Rheumatology Physician) - 84/100 vs national avg 83.1

0%100%National avg83%84%
MIPS final score (Rheumatology Physician) - 84/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Anna Kazaryan, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 2335 E KASHIAN LN STE 280, Fresno, CA, 93701, with a listed phone of (559) 256-9690. NPI 1689085888 was issued on 05/12/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Kazaryan most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,087 prescription claims written by this provider, covering 247 Medicare beneficiaries and totaling roughly $1.4 million in drug spend. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84/100 for the 2023 performance year (Quality 76.3, Cost 57.9), compared with the national average of 83.1.

Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2335 E KASHIAN LN STE 280
Fresno, CA 93701

Provider Details

NPI 1689085888
Specialty Rheumatology Physician
Credentials M.D.
Gender Female
NPI Issued 05/12/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

84.0043
Final Score
Avg: 83.1
76.2778
Quality
57.8836
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Anna Kazaryan, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Community Health Partners
Clovis, CA
Shingletown Medical Center
Shingletown, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anna Kazaryan, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Anna Kazaryan, M.D.. To verify Anna Kazaryan, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,087
Total Claims
$1.4M
Total Drug Cost
247
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,677
Total Day Supply
48,216
Generic Drug Cost
$47K
Antibiotic Claims
19

Patient Demographics

Average Patient Age
69.3 years
Avg HCC Risk Score
1.63
Gender Split
74% female / 26% male
Age Distribution
<65: 46, 65-74: 129, 75-84: 61, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Anna Kazaryan, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Hydroxychloroquine Sulfate
191
Methotrexate
Methotrexate Sodium
186
Prednisone
127
Leflunomide
68
Enbrel Sureclick
Etanercept
59
Diclofenac Sodium
35
Humira(Cf) Pen
Adalimumab
33
Alendronate Sodium
29
Mycophenolate Mofetil
28
Azathioprine
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Rheumatology Physician Overview

How Anna Kazaryan, M.D. fits within the Rheumatology Physician landscape nationally.

6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider

Anna Kazaryan, M.D.'s 1,087 claims are below the specialty average of 2,054.

Nearby Rheumatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Kazaryan.

Compare Rheumatology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Anna Kazaryan, M.D.'s specialty?
Anna Kazaryan, M.D. specializes in Rheumatology Physician and practices in Fresno, California. Credentials: M.D..
How much does Anna Kazaryan, M.D. prescribe under Medicare Part D?
In 2023, Anna Kazaryan, M.D. wrote 1,087 Medicare Part D claims totaling $1.4M in drug costs for 247 beneficiaries.
What is Anna Kazaryan, M.D.'s Medicare quality score?
Anna Kazaryan, M.D. has a CMS MIPS Final Score of 84/100 (Quality: 76.3, Cost: 57.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Anna Kazaryan, M.D. located?
Anna Kazaryan, M.D. is located at 2335 E KASHIAN LN STE 280, Fresno, CA, 93701. Phone: (559) 256-9690.
What is Anna Kazaryan, M.D.'s NPI number?
Anna Kazaryan, M.D.'s National Provider Identifier (NPI) is 1689085888, issued on 05/12/2014.
How many Rheumatology Physician providers are there in the US?
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does Anna Kazaryan, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Anna Kazaryan, M.D.'s most frequently prescribed drugs include Hydroxychloroquine Sulfate, Methotrexate, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anna Kazaryan, M.D. accept Medicare?
Anna Kazaryan, M.D. appears in CMS Medicare data with 1,087 Part D claims and 247 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anna Kazaryan, M.D.'s credentials?
Anna Kazaryan, M.D.'s NPI is 1689085888 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.